SOURCE: Pyng Medical Corp.

September 27, 2005 09:00 ET

Pyng Announces New Distribution Agreements for Europe, Puerto Rico and Barbados

VANCOUVER, BC -- (MARKET WIRE) -- September 27, 2005 --Pyng Medical Corp. (OTC: PYNGF) (TSX-V: PYT) is pleased to announce the following:

The company has entered into new distribution agreements for the F.A.S.T.1™ System for Adult Intraosseous Infusion for Germany, Spain, Portugal, Puerto Rico and Barbados.

Pyng Medical continues to expand its geographic base in Europe and the Caribbean and is currently producing product under the company's approved CE Mark for Europe. Translations required for the individual national regulatory processes, labeling and training documents, have been completed for German and are being finalized for Spanish, French, and other languages across Europe.

Medical Sales Consultants, Wein, Austria will now be distributing in Germany as well as Austria and have already delivered product to the German and Austrian military, as well as the Austrian and German Red Cross. Training sessions in both Austria and Germany, including major hospital and emergency medical sites in Munich, Berlin, and Vienna have been completed. European ongoing marketing activities include attendance at major conferences, training workshops and contacts with leading emergency medicine decision makers.

Orto-Medimatec located in Valladolid, Spain will distribute in Spain and Portugal. We have provided training on the F.A.S.T.1 System to all sales personnel at Orto-Medimatec in Spain who are now ready to sell and promote the product and we are currently preparing Spanish language translations for products to be shipped to Spain in the very near future.

Cardio Med Supply will be covering Puerto Rico where they have already delivered an initial quantity of F.A.S.T.1™ systems to the Puerto Rican emergency service.

A.S. Bryden & Sons (Barbados) Ltd. and Pyng Medical have entered into an agreement to distribute the FAST 1 System in Barbados and Pyng has delivered training systems to A.S. Bryden.

Pyng Medical has established distribution in the U.K. through Fenton Pharmaceuticals and the F.A.S.T.1™ System is now in use or in trials in several key areas such as Herefordshire, London, Staffordshire, and Hampshire. The British Special Forces and the Air force have also purchased systems. Our representatives in the U.K. continue to train across the country and exhibit at emergency medical conferences.

Pyng Medical Corp. continues to expand the presence of the F.A.S.T.1™ System in Europe and other geographic regions through our world-class distribution channels.

For further information please contact Pyng Medical Corp. at 1-604-303-7964 or visit our web site at www.pyng.com

Michael W. Jacobs, Chairman, Pyng Medical Corp.

The Toronto Venture Exchange has neither reviewed nor approved of the contents of this News Release. Safe Harbor Statement: This release may contain certain forward-looking statements including without limitation, projections, assumptions, expectations, product development objectives, commercial introduction, and potential advantages of the F.A.S.T.1™ System. Actual events or results may differ from the Company's expectations as a result of risk factors discussed in Pyng Medical Corp. reports on file.

Contact Information

  • For further information please contact:
    Pyng Medical Corp.
    1-604-303-7964
    www.pyng.com